65,437 trials
Essential Hypertension
Primary: Change From Baseline to End of Treatment in the Mean Seated Trough Cuff Diastolic Blood Pressure (DBP). — -15.7; -13.2; -9.5 mmHg — p=0.025
Healthy
Primary: Change in Sodium Blood Levels — -0.1; 0.2 mmol/L
Cerebral Arterial Diseases
Primary: Technical Failure Rate — 3.55; 29.22; 1.57; 17.65 percentage of arterial segments
Hypertension, Renal
Primary: The Incidence of Major Cardiovascular and/or Renal Adverse Events Related to the Renal Denervation Procedure That Occurred Within 30 Days Post-procedure. — 0.0…
Scleritis
Primary: Number of Participants With at Least a 2-step Reduction or Reduction to Grade 0 in Scleral Inflammation in the Study Eye (or Eyes), According to the National Eye…
Breast Cancer
Primary: Percentage of Participants Achieving a Best Overall Response of Confirmed Complete Response (CR) or Partial Response (PR) — 4.9; 0 percentage of participants
Healthy Participants
Primary: BOLD Signal Measured by Functional Magnetic Resonance Imaging (fMRI) — 0.1631; 0.5079 parameter estimates (arbitrary units)
Inguinal Hernia
Primary: Number of Patients With Inguinal Hernia Recurrence — 3; 0 participants — p=0.11
Rheumatoid Arthritis · Hypovitaminosis D
Primary: Parathyroid Hormone Level — 19; 20 pg/mL
Breast Reconstruction · Contour Irregularities · Volume Insufficiency
Primary: Volume Maintenance — 51.6; 78.9 percentage of graft volume persistency — p=0.310
Chronic Kidney Disease
Primary: the Occurrence of Cardiovascular Event and Peritonitis Events — 0; 0; 0; 0 participants — p=>0.05
Cerebrovascular Diseases · Stroke · Cardiovascular Diseases
Primary: Change in Systolic Blood Pressure — 0.19; -9 mmHg — p=0.96
Kidney Cancer
Primary: Progression Free Survival — 9.6 months
Chronic Myeloproliferative Disorders · Leukemia · Lymphoma
Primary: Transplant-related Mortality — 18 percentage of participants
Acute Pancreatitis
Primary: The T2* Values in the Diagnosis of AP — 25.86; 21.06 ms — p=<0.01